Cai and colleagues (108) found that activated T cell exosomes release FasL in mouse models of melanoma and lung cancer, which increases the expression of matrix metalloproteinase 9 via the Fas signaling pathway, thus improving the invasive potential of the tumor, thus providing new perspectives for understanding tumor evasion from immune surveillance. The gene discussed is FAS; the disease is neoplasm.